Lorlatinib can control ALK+ #lungcancer for yrs but side effects often get in the way. This new guide, shaped by people with ALK, shows how dose reductions (like 75mg) & other strategies can help people stay on trtmt without suffering through it. 🔗 www.lungcancerjournal.info/article/S016... #LCSM